Overview
BDH Industries (BDHIL) manufactures a wide range of drug formulations, focusing on antibiotics, anti-inflammatory, and anti-microbial segments. It offers robust Oral Solid Dosages (OSD) technologies.
The company boasts a well-equipped R&D center in Mumbai, dedicated to developing novel drug delivery systems, signaling a commitment to innovation.
BDHIL has entered into a MoU with Nepal's Nepothene Group to assist in setting up a pharmaceutical company, indicating international strategic collaboration.
They expanded into the agro products business as of 2021-22, diversifying their business portfolio.
BDHIL invested in renewable energy by commissioning two wind turbine units, highlighting their drive towards sustainability.
- Sector
Pharmaceuticals & Biotechnology
- Industry
Pharmaceuticals
- Market Cap
232 Cr
- Volatility
Low Risk
- P/E Ratio
21.5
- Industry P/E
34.3
- PEG Ratio
2.5
- P/B Ratio
3.1
- 52W High
523.75
- 52W Low
257.05
Financial Ratios
Sales CAGR
- 1Y
- -22.51%
- 3Y
- -1.41%
- 5Y
- 2.26%
- 10Y
- 4.00%
Profit CAGR
- 1Y
- -6.08%
- 3Y
- 8.69%
- 5Y
- 9.31%
- 10Y
- 12.45%
ROE
- TTM
- 14.04%
- 3Y
- 14.73%
- 5Y
- 14.76%
- 10Y
- 14.17%
ROCE
- TTM
- 19.30%
- 3Y
- 19.77%
- 5Y
- 19.90%
- 10Y
- 19.58%
Technicals
Oscillators
Bullish
Bearish
5
Neutral
3
Bullish
6
Overall
Bullish
Bearish
6
Neutral
3
Bullish
37
Moving Averages
Bullish
Bearish
1
Neutral
0
Bullish
31
Actions
AI Mode
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Ask AI
